Skip to main navigation
Top Links - Left
BioNTech.comNewsroomInvestorsHealthcare Professionals
Language switcher (Content)
  • English
  • German
Top Links - Right Connect
Main Navigation
  • Newsroom
  • Events & Presentations
  • Financials

  • SEC Filings
  • Annual Reports
  • Quarterly Reports
  • Financial Calendar
  • Corporate Governance

  • Overview
  • Transparency
  • ESG
  • Stock Info

  • Stock Quote & Chart
  • Analyst Coverage
  • Shareholder Fraud Warning
  • Share Repurchase Program
  • Dividend Information
  • Annual Information Statements
  • Investor FAQs
  • Information on CureVac Post-Offer Reorganization
  • CureVac Offer Archive
  • Form 8937
  • Annual General Meeting

  • Annual General Meeting 2026
  • Annual General Meeting Archive
  • Contact Us
  • Newsroom
  • Investors
  • Healthcare Professionals
  • Breadcrumb
    1. Investors
    2. Q4 2025

    Q4 2025

    Display Title
    Q4 2025
    Weight
    0
    Sub-group
    Q4
    Group
    2025
    Content
    Fourth Quarter and Full Year 2025 Press Release
    Fourth Quarter and Full Year 2025 Webcast
    Fourth Quarter and Full Year 2025 Earnings Presentation 2.1 MB
    20-F 4.9 MB
    Bundled Content Type
    Quarterly Results

    BioNTech SE

    An der Goldgrube 12

    55131 Mainz, Germany

    T: +49 6131 9084-0

    F: +49 6131 9084-2121

    service@biontech.de

    Company
    AboutResearch & InnovationPipelineManufacturingCareersCovid-19
    Quick Links
    NewsroomInvestorsHealthcare ProfessionalsConnectSuppliers
    Footer Links - Bottom Terms of UseGeneral Terms and ConditionsGeneral Conditions of PurchaseData Privacy StatementAdverse Event ReportingImprintCookie Settings
    Footer Social Links
    Twitter
    Linkedin

    © 2026  BioNTech
    All rights reserved